Author:
Yamaue Hiroki,Shimizu Atsushi,Hagiwara Yasuhiro,Sho Masayuki,Yanagimoto Hiroaki,Nakamori Shoji,Ueno Hideki,Ishii Hiroshi,Kitano Masayuki,Sugimori Kazuya,Maguchi Hiroyuki,Ohkawa Shinichi,Imaoka Hiroshi,Hashimoto Daisuke,Ueda Kazuki,Nebiki Hiroko,Nagakawa Tatsuya,Isayama Hiroyuki,Yokota Isao,Ohashi Yasuo,Shirasaka Tetsuhiko
Funder
Taiho Pharmaceutical
Kyowa Hakko Kirin
Ajinomoto Pharmaceuticals
Otsuka Pharmaceutical
Mochida Pharmaceutical Company
Daiichi-Sankyo
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference31 articles.
1. National Cancer Institute: SEER Cancer Statistics Factsheets: Pancreas Cancer. http://seer.cancer.gov/statfacts/html/pancreas.html . Accessed 10 Jan 2017
2. Ministry of Health, Labour and Welfare of Japan: [Vital Statistics Japan]. http://ganjoho.jp/reg_stat/statistics/stat/index.html . Accessed 10 Jan 2017
3. Shirasaka T, Shimamato Y, Ohshimo H et al (1996) Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs 7:548–557
4. Tatsumi K, Fukushima M, Shirasaka T, Fujii S (1987) Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts. Jpn J Cancer Res 78:748–755
5. Shirasaka T, Shimamoto Y, Fukushima M (1993) Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats. Cancer Res 53:4004–4009
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献